Migdal Insurance & Financial Holdings’s Protolabs PRLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-38
Closed -$4K – 751
2019
Q4
$4K Sell
38
-2,563
-99% -$254K ﹤0.01% 725
2019
Q3
$266K Sell
2,601
-427
-14% -$43.5K 0.01% 430
2019
Q2
$351K Buy
3,028
+571
+23% +$61.5K 0.01% 355
2019
Q1
$258K Sell
2,457
-105
-4% -$11.8K 0.01% 374
2018
Q4
$289K Sell
2,562
-1,094
-30% -$135K 0.01% 319
2018
Q3
$591K Buy
3,656
+165
+5% +$23.3K 0.01% 345
2018
Q2
$415K Buy
3,491
+1,188
+52% +$145K 0.01% 338
2018
Q1
$271K Buy
+2,303
New +$260K 0.01% 337

Other funds holding PRLB

Migdal Insurance & Financial Holdings's PRLB Position: Q1 2020 in Review

Migdal Insurance & Financial Holdings sold out of Protolabs (PRLB) in Q1 2020, closing a stake of 38 shares — an estimated $4K sold.

Migdal Insurance & Financial Holdings first reported a position in PRLB in Q1 2018 and held it in 8 quarters. The position peaked at $591K in Q3 2018. 234 funds tracked by Wall St. Rank hold PRLB as of Q1 2020.

  • Migdal Insurance & Financial Holdings reported no remaining Protolabs position as of Q1 2020 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 38 Protolabs shares in Q1 2020, an estimated $4K.
  • Migdal Insurance & Financial Holdings first reported a position in Protolabs in Q1 2018 and held it in 8 quarters.
  • Migdal Insurance & Financial Holdings's Protolabs position peaked at $591K in Q3 2018.
  • 234 funds tracked by Wall St. Rank held Protolabs as of Q1 2020.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q1 2020, filed 12 May 2020.